Versor Investments’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.1M | Buy |
5,397
+2,898
| +116% | +$1.13M | 0.37% | 30 |
|
2025
Q1 | $1.09M | Buy |
+2,499
| New | +$1.09M | 0.18% | 177 |
|
2024
Q4 | – | Sell |
-875
| Closed | -$455K | – | 816 |
|
2024
Q3 | $455K | Buy |
+875
| New | +$455K | 0.07% | 447 |
|
2024
Q2 | – | Sell |
-1,801
| Closed | -$934K | – | 785 |
|
2024
Q1 | $934K | Buy |
+1,801
| New | +$934K | 0.19% | 157 |
|
2023
Q4 | – | Sell |
-487
| Closed | -$212K | – | 750 |
|
2023
Q3 | $212K | Sell |
487
-879
| -64% | -$383K | 0.04% | 578 |
|
2023
Q2 | $607K | Sell |
1,366
-1,134
| -45% | -$504K | 0.11% | 204 |
|
2023
Q1 | $1.15M | Buy |
+2,500
| New | +$1.15M | 0.15% | 91 |
|
2022
Q4 | – | Sell |
-3,011
| Closed | -$1.37M | – | 791 |
|
2022
Q3 | $1.37M | Buy |
3,011
+1,508
| +100% | +$685K | 0.08% | 149 |
|
2022
Q2 | $725K | Buy |
1,503
+600
| +66% | +$289K | 0.03% | 358 |
|
2022
Q1 | $444K | Buy |
+903
| New | +$444K | 0.02% | 362 |
|
2020
Q3 | – | Sell |
-2,489
| Closed | -$655K | – | 302 |
|
2020
Q2 | $655K | Buy |
2,489
+667
| +37% | +$176K | 0.06% | 56 |
|
2020
Q1 | $414K | Sell |
1,822
-2,634
| -59% | -$599K | 0.03% | 133 |
|
2019
Q4 | $1.35M | Sell |
4,456
-9,200
| -67% | -$2.78M | 0.07% | 105 |
|
2019
Q3 | $3.28M | Buy |
13,656
+2,600
| +24% | +$624K | 0.22% | 46 |
|
2019
Q2 | $3.12M | Buy |
11,056
+5,550
| +101% | +$1.57M | 0.21% | 69 |
|
2019
Q1 | $1.58M | Buy |
+5,506
| New | +$1.58M | 0.15% | 68 |
|